<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJOC</journal-id><journal-title-group><journal-title>International Journal of Organic Chemistry</journal-title></journal-title-group><issn pub-type="epub">2161-4687</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijoc.2017.72007</article-id><article-id pub-id-type="publisher-id">IJOC-76410</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Synthesis, Molecular Structure and Antibacterial Activity of Benzylmethyl-4-Methyl-3-Thiosemicarbazone
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>James</surname><given-names>A. Mbah</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Godfred</surname><given-names>A. Ayimele</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Elvis</surname><given-names>N. Eyonganyoh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Emmanuel</surname><given-names>N. Nfor</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Chemistry, University of Buea, Buea, Cameroon</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>mbah_james@yahoo.com(JAM)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>05</month><year>2017</year></pub-date><volume>07</volume><issue>02</issue><fpage>83</fpage><lpage>90</lpage><history><date date-type="received"><day>March</day>	<month>22,</month>	<year>2017</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>May</month>	<year>21,</year>	</date><date date-type="accepted"><day>May</day>	<month>24,</month>	<year>2017</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  A novel Schiff base, benzylmethyl-4-methyl-3-thiosemicarbazone (
  BMM) de-rived from benzylmethylketone and 4-methylthiosemicarbazide was synthe-sized and characterized by elemental analysis, spectroscopic methods (IR, 
  <sup>1</sup>H NMR, 
  <sup>13</sup>C NMR) and physical means. The single crystal structure analysis of the Schiff base reveals that it crystallizes in a monoclinic system in the P2
  <sub>1</sub>/c space group. 
  BMM revealed moderate antibacterial activity on three bacterial strains with diameter zone of inhibition of 16 mm (
  E. coli), 14 mm (
  K. pneumonia) and 13 mm (
  S. epider-midis) compared with the standard drug, ciprofloxacin.
 
</p></abstract><kwd-group><kwd>Benzylmethyl-4-Methyl-3-Thiosemicarbazone</kwd><kwd> Antibacterial Activity</kwd><kwd> Crystal  Structure</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Benzylmethylketone, also known as phenyl-2-propanone occurs as a metabolite of amphetamine via oxidative deamination. It is used as an intermediate in the production of pesticides, rodenticides and anticoagulants [<xref ref-type="bibr" rid="scirp.76410-ref1">1</xref>] . On the other hand, thiosemicarbazones are useful in the medicinal and pharmaceutical fields because of their great significant pharmacological properties such as antibacterial [<xref ref-type="bibr" rid="scirp.76410-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.76410-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.76410-ref4">4</xref>] , antifungal [<xref ref-type="bibr" rid="scirp.76410-ref2">2</xref>] , anti-HIV [<xref ref-type="bibr" rid="scirp.76410-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.76410-ref6">6</xref>] , anticancer [<xref ref-type="bibr" rid="scirp.76410-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.76410-ref8">8</xref>] , antineoplastic [<xref ref-type="bibr" rid="scirp.76410-ref9">9</xref>] , anti-inflammatory [<xref ref-type="bibr" rid="scirp.76410-ref10">10</xref>] , tuberclostatic [<xref ref-type="bibr" rid="scirp.76410-ref11">11</xref>] and their variable bonding nature. The biological activities of thiosemicarbazones often depend on the parent aldehyde or ketone. In recent years, we have been working on the synthesis of heterocyclic thiosemicarbazone, their metal complexes and biological activities [<xref ref-type="bibr" rid="scirp.76410-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.76410-ref13">13</xref>] . As part of our ongoing studies, in this paper, we describe synthesis, IR, NMR and single crystal X-ray structure of BMM. The antibacterial studies of the novel Schiff base were carried out against: Staphylococcus epidermidis, Bacillus cereus, Escherichi coli and Klebsiella pneumoniae.</p></sec><sec id="s2"><title>2. Experimental</title><sec id="s2_1"><title>2.1. Materials</title><p>Benzylmethylketone, 4-methylthiosemicarbazide, ethanol and acetic acid were used as purchased without further purification. Elemental analysis was performed on a VARIO EL (Heraeus) analyzer. IR spectrum was obtained from a Perkin-Elmer System 2000 FT-IR spectrophotometer using KBr pellets. The mass spectrum (ESI) was recorded with an FT-IR (APEX II) mass spectrometer from Bruker Daltonics and NMR spectra were run in CD<sub>3</sub>COCD<sub>3</sub> on a 400 MHz spectrometer. Melting point was recorded on a Gallen-Kamp melting point apparatus and is uncorrected. Elemental analysis was performed on a Thermo Flash EA-1112 Series CHNS-O Elemental Analyzer.</p></sec><sec id="s2_2"><title>2.2. Synthesis of Benzylmethyl-4-Methyl-3-Thiosemicarbazone (BMM)</title><p>A suspension of 4-methylthiosemicarbazide (210 mg, 0.002 mol) dissolved in 15 ml ethanol was added to a solution of benzylmethylketone (0.27 mL, 0.002 mol). Five (05) drops of glacial acetic acid were added to the mixture. The reaction mixture (colourless) was allowed to reflux for 6 hours (Scheme 1) at a temperature of 70˚C. The yellowish filtrate which was allowed to cool, formed suitable crystals for X-ray diffraction studies.</p><p>Yield: 80%. Mp: 130˚C. Anal. Calcd for C<sub>11</sub>H<sub>15</sub>N<sub>3</sub>S: C 59.69%; H 6.83%; N 18.99% and S 14.49%. Experimental: C 56.69%; H 7.32%; N 19.71% and S 14.60%. IR (KBr, cm<sup>−1</sup>): 1545 (C=N); 1122 (C=S); 3225 and 3330 (2N-H); 850 (N-N). ESI [m/z (%)]: 221.1 (M, 52); 165.1 (22); 130.0 (100); 91.0 (41). <sup>1</sup>H NMR (δ ppm): 1.93 (CH<sub>3</sub>-C=C); 3.13 (CH<sub>3</sub>-N); 3.59 −CH<sub>2</sub>-Ar); 7.21 - 7.34 (broad, alkyl substituted benzene ring); 8.15 (N-H at position 4) and 8.51 (N-H and position 2). <sup>13</sup>C NMR(δ ppm): 179.9 (C=S); 150.5 (C=N); 137.3 -126.7 (aromatic carbons); 44.7 (-CH<sub>2</sub>-Ar); 36.1 (CH<sub>3</sub>-4) and14.3 (CH<sub>3</sub>-C=N).</p></sec><sec id="s2_3"><title>2.3. Single Crystal X-Ray Diffraction Analysis and Structure Determination</title><p>This was performed using standard procedures as reported by Nfor et al. [<xref ref-type="bibr" rid="scirp.76410-ref14">14</xref>] . Briefly, suitable-single crystal of BMM was mounted in air unto a loop. The data collection for BMM was carried out with a Bruker DUO APEX II CCD diffractometer at temperature controlled using an Oxford cryostream-700. Data reduction and cell refinement were performed using SAINT-Plus, and the space group was determined from systematic absences by XPREP and further justified by the refinement results. Graphite monchromated MoKα (λ = 0.71073 &#197;) radiation was used. The X-ray diffraction data have corrected for Lorentz-polarization factor and scaled for absorption effects by multi-scan using SADABS. The struc- ture was solved by direct method, implemented in SHELXS-97. Refinement procedure by full-matrix least-square method based on P<sup>2</sup> values against reflections have been performed by SHELX-97, including anisotropic displacement parameters for all non-H atoms. The positions of hydrogen atoms belonging to the carbon atoms were geometrically optimized by applying a riding model. Calculations concerning the molecular geometry, the affirmation of chosen space groups and the analysis of hydrogen bonds were performed with PLATON. The molecular graphic was done with ORTEP-3 and Mercury (version 3.0).</p></sec><sec id="s2_4"><title>2.4. Antimicrobial Activity</title><p>The antibacterial activity of the BMM was determined using a modified Kirby- Bauer disc diffusion method [<xref ref-type="bibr" rid="scirp.76410-ref15">15</xref>] . The antibacterial activity was done by using gram +ve organisms: Staphylococcus epidermidis and Bacillus cereus as well as gram ?ve organisms: Escherichi coli and Klebsiella pneumoniae. Ciprofloxacin was used as the standard. The percent activity index for the antibacterial was calculated as reported in literature [<xref ref-type="bibr" rid="scirp.76410-ref16">16</xref>] .</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><p>The condensation reaction between benzylmehtylketone and 4-methylthiose- micarbazide gave benzylmethyl-4-methyl-3-thiosemcarbazone in good yield (Scheme 1).</p><sec id="s3_1"><title>3.1. Elemental Analyses</title><p>The elemental analysis for C, H, N and S revealed that the calculated and experimental data for the Schiff base are in good agreement suggesting the high percent purity of the compound which was further confirmed by mass spectrometry.</p></sec><sec id="s3_2"><title>3.2. Infrared Spectrum</title><p>The infrared spectrum (<xref ref-type="fig" rid="fig1"><xref ref-type="fig" rid="fig">Figure </xref>1</xref>) was taken in 4000 - 400 cm<sup>−1</sup> region. Two bands between 3330 and 3225 cm<sup>−1</sup> representing stretching frequencies for the two N-H groups. Two bands between 690 and 760 cm<sup>−1</sup> indicating the presence of a monosubstituted benzene ring. Other important bands were observed at 1545 cm<sup>−1</sup> (C=N) and 1122 cm<sup>−1</sup> (C=S).</p></sec><sec id="s3_3"><title>3.3. <sup>1</sup>H NMR Spectrum</title><p>The <sup>1</sup>H NMR spectrum (<xref ref-type="fig" rid="fig">Figure </xref>S1) of benzylmethyl-4-methyl-3-thiosemcarba-</p><disp-formula id="scirp.76410-formula1"><graphic  xlink:href="http://html.scirp.org/file/1-1020529x2.png"  xlink:type="simple"/></disp-formula><p>Scheme 1. Synthesis of benzylmethyl-4-methyl-3-thiosemicarbazone.</p><p>zone was recorded in CD<sub>3</sub>COCD<sub>3</sub>. Prominent peaks were observed at 1.93 ppm corresponding to a methyl group attached to an sp<sup>2</sup> carbon, 3.13 ppm indicating a methyl group on a nitrogen atom and a broad singlet between 7.21 - 7.34 ppm suggesting that the aromatic ring is substituted by an alkyl group [Supple- mentary file].</p></sec><sec id="s3_4"><title>3.4. <sup>13</sup>C NMR Spectrum</title><p>The <sup>13</sup>C NMR spectrum (<xref ref-type="fig" rid="fig">Figure </xref>S2) of benzylmethyl-4-methyl-3-thiosemcarba- zone was recorded in CD<sub>3</sub>COCD<sub>3</sub>. The most deshielded peak appeared at 179.9 ppm and was attributed to C=S, followed by a peak at 150.5 ppm which was assigned to C=N. Signals for the aromatic carbon atoms were observed in the range, 137.3 - 126.7 ppm while the methylene carbon atom directly attached to the aromatic ring was seen at 44.7 ppm.</p></sec><sec id="s3_5"><title>3.5. Single Crystal X-Ray Crystallography</title><p>The molecular structure of the Schiff base is shown in <xref ref-type="fig" rid="fig">Figure </xref>2 along with the atomic numbering scheme. The Schiff base crystallises in the monoclinic system in space group P2<sub>1</sub>/c. The unit cell dimensions are a = 10.1942 (9) &#197;, b = 11.9005 (10 &#197; and c = 10.5254 (10) &#197; with the cell angles being α = 90.00, β = 113.089 (2) and χ = 90.00.</p><p>The crystal structure of the molecule is in line with the IR, NMR and elemental analysis data of the molecule. It shows the possibility of hydrogen bonding (<xref ref-type="fig" rid="fig">Figure </xref>3).</p></sec><sec id="s3_6"><title>3.6. Antimicrobial Activity of Benzylmethyl-4-Methyl-3-Thiosemcarbazone (BMM)</title><p>The antibacterial activity of BMM as shown on <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>BMM was found to be moderately active against three strains of bacteria. The</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1"><xref ref-type="fig" rid="fig">Figure </xref>1</xref></label><caption><title> IR spectrum of BMM</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1020529x3.png"/></fig><p>antibacterial activity of BMM may be attributed to the presence of toxophorically important imine group (-C=N) where the mode of action of such compounds may involve the formation of hydrogen bond through azomethine group with the active centre of the cell constituents, thereby resulting in the interference with normal cell processes [<xref ref-type="bibr" rid="scirp.76410-ref17">17</xref>] . This is the first report of benzylmethyl-4-methyl-3-thio- semicarbazone on bacteria. Given the promiscuity of thiosemicarbazones, BMM will be screened on other pathogens such as malaria and onchocerciasis.</p></sec></sec><sec id="s4"><title>4. Conclusion</title><p>A novel compound, benzylmethyl-4-methyl-3-thiosemcarbazone (BMM) de-</p><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig">Figure </xref>2</label><caption><title> Crystal structure of BMM with atom numbering scheme</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1020529x4.png"/></fig><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig">Figure </xref>3</label><caption><title> Intermolecular hydrogen bonding of the Schiff base</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1020529x5.png"/></fig><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Diameter of inhibition zone of bacterial strains by BMM at disc potency of 100 μg/mL</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Compound</th><th align="center" valign="middle"  rowspan="2"  >Conc (μg/mL)</th><th align="center" valign="middle"  colspan="4"  >Diameter of inhibition zone (mm)</th></tr></thead><tr><td align="center" valign="middle" >EC</td><td align="center" valign="middle" >KP</td><td align="center" valign="middle" >BC</td><td align="center" valign="middle" >SE</td></tr><tr><td align="center" valign="middle" >BMM</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >13</td></tr><tr><td align="center" valign="middle" >Ciprofloxacin (standard)</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >28</td></tr></tbody></table></table-wrap><p>NA = Not Active; EC = Escherichi coli; KP = Klebsiella pneumonia; BC = Bacillus cereus; SE = Staphylococcus epidermidis and BMM = benzylmethyl-4-methyl-3-thiosemicarbazone.</p><p>rived from benzylmethylketone and 4-methylthiosemicarbazide was synthesized and characterized by spectroscopic and physical means. The crystal structure of BMM is being reported for the first time. BMM revealed moderate antibacterial activity on three bacterial strains with diameter zone of inhibition of 16 mm (E. coli), 14 mm (K. pneumonia) and 13 mm (S. epidermidis) for the first time, suggesting that such compounds could be exploited as antibacterial leads. In vivo screening and toxicity studies will be done to ascertain its possibility as a lead for drug or prodrug development.</p></sec><sec id="s5"><title>Acknowledgements</title><p>We greatly acknowledge Prof. Susan Bourne, of the State Center of Supramo- lecular Chemistry, Cape Town University for sponsoring the spectral analyses of this compound. We thank Dr. Agha Innocent of Bamenda General Hospital for the antibacterial studies.</p></sec><sec id="s6"><title>Cite this paper</title><p>Mbah, J.A., Ayimele, G.A., Eyonganyoh, E.N. and Nfor, E.N. (2017) Synthesis, Molecular Structure and Antibacterial Activity of Benzylmethyl- 4-Methyl-3-Thiosemicarbazone. International Journal of Organic Chemistry, 7, 83- 90. https://doi.org/10.4236/ijoc.2017.72007</p></sec><sec id="s7"><title>Supplementary File</title><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig">Figure </xref>S1</label><caption><title> <sup>1</sup>H NMR spectrum of BMM</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1020529x6.png"/></fig><fig id="fig5"  position="float"><label><xref ref-type="fig" rid="fig">Figure </xref>S2</label><caption><title> <sup>13</sup>C NMR spectrum of BMM</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1020529x7.png"/></fig></sec></body><back><ref-list><title>References</title><ref id="scirp.76410-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Gionani, S.D., Varriale, A., Marzullo, V.M., Ruggiero, G., Staiano, M., Secchi, A., Pierno, L., Fiorello, A.M. and D’Auria, S. (2012) Determination of Benzylmethylketone—A Commonly Used Precursor in Amphetamine Manufacture. Analytical Methods, 4, 3558-3564. https://doi.org/10.1039/c2ay25772f</mixed-citation></ref><ref id="scirp.76410-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Parul, N., Subhangkar, N. and Mahato, A. (2012) Antimicrobial Activity of Different Thiosemicarbazone Compounds against Microbial Pathogens. International Research Journal of Pharmacy, 3, 350-363.</mixed-citation></ref><ref id="scirp.76410-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Abou-Mehla, K.S. and Faruk, H. (2008) Bimetallic Complexes of Schiff Base Bis-[4-hydroxycoumarin-3-yl]-1N,5N-thiocarbohydrazone as a Potentially Dibasic Pentadentate Ligand. Synthesis, Spectral and Anti-microbial Properties. Journal of the Iranian Chemical Society, 5, 122-134. https://doi.org/10.1007/BF03245825</mixed-citation></ref><ref id="scirp.76410-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Patil, S.A., Naik, V.H., Kulkarni, A.D. and Badami, P.S. (2010) DNA Cleavage, Antimicrobial, Spectroscopic and Fluorescence Studies of Co(II), Ni(II) and Cu(II) Complexes with SNO Donor Coumarin Schiff Bases. Spectrochimica Acta A, 75, 347-354. https://doi.org/10.1016/j.saa.2009.10.039</mixed-citation></ref><ref id="scirp.76410-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Teytz, Y., Ronen, D., Vansover, A., Stematsky, T. and Riggs, J.L. (1994) Inhibition of Human Immunodeficiency Virus by N-methylisatin-beta 4':4'-Diethylthiosemi- carbazoneand N-Allylisatin-beta4':4'-diallythiosemicarbazone. Antiviral Research, 24, 305-314. https://doi.org/10.1016/0166-3542(94)90077-9</mixed-citation></ref><ref id="scirp.76410-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Teytz, Y., Barko, N., Abramoff, M. and Ronen, D. (1994) Relationships between Structure and Antiretroviral Activity of Thiosemicarbazone Derivatives. Chemotherapy, 40, 195-200. https://doi.org/10.1159/000239192</mixed-citation></ref><ref id="scirp.76410-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Hall, I.H., Wong, O.T. and Chapman, J.M. (1995) Cytotoxicity of Imides-N-alkyl Semicarbazones, Thiosemicarbazones, Acetyl Hydrazones and Related Derivatives. Anticancer Drugs, 6, 147-153. https://doi.org/10.1097/00001813-199502000-00017</mixed-citation></ref><ref id="scirp.76410-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Tahmeena, K., Rumana, A., Seema, J. and Khan, A.R. (2015) Anti-cancer Potential of Metal Thiosemicarbazone Complexes: A Review. Der Chemica Sinica, 6, 1-11.</mixed-citation></ref><ref id="scirp.76410-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Liu, M., Lin, T. and Sartorelli, A.C. (1992) Synthesis and Antitumor Activity of Amino Derivatives of Pyridine-2-Carboxaldehyde Thiosemicarbazone. Journal of Medicinal Chemistry, 35, 3672-3677. https://doi.org/10.1021/jm00098a012</mixed-citation></ref><ref id="scirp.76410-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Mignot, A., Miocque, M., Binet, P., Rapin, J.R., Rinjard, P., Roux, M., Cals, M.J. and Ekindjian, J.C. (1980) Thiosemicarbazones d'aldéhydes Aromatiques Antiinflammatoires: Pharmacologie, étude pharmacocinétique preliminaire, action sur le fibroblaste en culture. European Journal of Medicinal Chemistry, 15, 33-40.</mixed-citation></ref><ref id="scirp.76410-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Bemstein, J., Yale, H.L., Losee, K., Holsing, M., Martins, J. and Lott, W.A. (1951) The Chemotherapy of Experimental Tuberculosis. III. The Synthesis of Thiosemicarbazones and Related Compounds. Journal of the American Chemical Society, 73, 906-912. https://doi.org/10.1021/ja01147a007</mixed-citation></ref><ref id="scirp.76410-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Nfor, E.N., Esemu, S.N., Ayimele, G.A., Ededet, A.E., Iniama, G.E. and Offiong, E.O. (2011) Copper (II) and Nickel (II) Complexes of 4-Phenylsemicarbazones: Synthesis, Stereochemistry and Antimicrobial Activity. Bulletin of the Chemical Society of Ethiopia, 25, 361-370. https://doi.org/10.4314/bcse.v25i3.68668</mixed-citation></ref><ref id="scirp.76410-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Majoumo-Mbe, F., Nde, D.T., Mukoko, I.N., Offiong, E.O. and Nfor, E.N. (2016) Synthesis, Crystal and Molecular Structure of Manganese (II) Complex of 2-Acetylpyridine N(4) Ethylthiosemicarbazone. Communications in Inorganic Synthesis, 4, 5-11.</mixed-citation></ref><ref id="scirp.76410-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Nfor, E.N., Ahmad, H., Majoumo-Mbe, F., Njah, I.N., Offiong, E.O. and Bourne, S. (2013) Synthesis, Crystal Structure and Antifungal Activity of a Ni(II) Complex of a New Hydrazone Derived from Anti-hypertensive Drug Hydralazine Hydrochloride. Polyhedron, 63, 207-213. https://doi.org/10.1016/j.poly.2013.07.028</mixed-citation></ref><ref id="scirp.76410-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Bauer, A.W., Kirby, W.M., Sherris, C. and Turck, M. (1966) Antibiotic Susceptibility Testing by a Standardized Single Disc Method. American Journal of Clinical Pathology, 45, 493-499.</mixed-citation></ref><ref id="scirp.76410-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">El-Sherif, A.A., Shoukry, M.M. and Abobakr, L.O. (2013) Bivalent Transition Metal Complexes of Cetirizines: Spectroscopic, Equilibrium Studies and Biological Activity. Spectrochimica Acta (A), 112, 290-300.</mixed-citation></ref><ref id="scirp.76410-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">El-Sherif, A.A. and Shoukry, M.M. (2007) Ternary Copper(II) Complexes Involving 2-(aminomethyl)-benzimidazole and Some Bio-Relevant Ligands. Equilibrium Studies and Kinetics of Hydrolysis for Glycine Methyl Ester under Complex Formation. Inorganica Chimica Acta, 360, 473-487.</mixed-citation></ref></ref-list></back></article>